PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88647018 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 103 |
MARK SECTION | |
MARK | PYLARIFY (see, http://uspto.report/TM/88647018/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | PYLARIFY |
OWNER SECTION (current) | |
NAME | Progenics Pharmaceuticals, Inc. |
INTERNAL ADDRESS | One World Trade Center |
MAILING ADDRESS | 47th Floor Suite J |
CITY | New York |
STATE | New York |
ZIP/POSTAL CODE | 10007 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
OWNER SECTION (proposed) | |
NAME | Progenics Pharmaceuticals, Inc. |
INTERNAL ADDRESS | One World Trade Center |
MAILING ADDRESS | 47th Floor Suite J |
CITY | New York |
STATE | New York |
ZIP/POSTAL CODE | 10007 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | Douglas R. Wolf |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | drwtrademarks@wolfgreenfield.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Douglas R. Wolf |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | drwtrademarks@wolfgreenfield.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | P11762002800 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 042 |
CURRENT IDENTIFICATION | Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; Providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 044 |
CURRENT IDENTIFICATION | Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; Web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 2 |
ONGOING EFFORT | product or service research or development ; market research |
ALLOWANCE MAIL DATE | 04/21/2020 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 2 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 250 |
TOTAL AMOUNT | 250 |
SIGNATURE SECTION | |
SIGNATURE | /drw/ |
SIGNATORY'S NAME | Douglas R. Wolf |
SIGNATORY'S POSITION | Attorney of Record |
DATE SIGNED | 04/09/2021 |
SIGNATORY'S PHONE NUMBER | 617-646-8000 |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Fri Apr 09 12:58:03 ET 2021 |
TEAS STAMP | USPTO/ESU-XX.XXX.XX.X-202 10409125803310590-8864701 8-770b33541f9542e6861e539 d7b813c8d3f4496273f9b5de2 8c8d66a76a69f3823-CC-5800 1885-20210409125119598062 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |